Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – June 30, 2019

Matt Turner
Patient Affordability

Matthew Durham
Omnidynamic Marketing

Stacey Gandler
Brand Nourishment

Paul Theisen
Patient Acquisition

Daniel Sontupe
Market Access

Bud Bilanich
Success Coach

Frank Burrell
Scientific Storytelling

David Linetsky
Point-of-Care Marketing

Liz Kane
Impactful Strategy

Joey Cohen
Medication Adherence

Amy Giles
Increasing Engagement

Pat Purcell
Meeting Engagement

Brenda Snow
Authentic Patient Voice

Suma Ramadas, PhD
Medical Affairs